Quadrupole Moment Measurements of TSD1 and TSD2 Bands in ¹⁶⁷Lu

Quadrupole Moment Measurements of TSD1 and TSD2 Bands in 167Lu

The triaxial strongly deformed (TSD) bands in 167Lu were populated by the 123Sb(48Ca, 4n) reaction with a beam energy of 203 MeV. Gamma rays, requiring five fold or more in prompt coincidence, were detected with the Gammasphere spectrometer. Of particular interests are TSD bands 1 and 2 which have previously been interpreted as zero phonon and one phonon wobbling bands, respectively. Using the ...

Measurement of Conversion Coefficients in Normal and Triaxial Strongly Deformed Bands in ¹⁶⁷Lu

Preparation and biodistribution assessment of low specific activity 177Lu-DOTATOC for optimization studies

Introduction: Somatostatin receptors expressed on a wide range of human tumors, are potential targets for the peptide receptor radionuclide therapy (PRRT). In this study, 177Lu-[DOTA-DPhe1, Tyr3]octreotide (177Lu-DOTATOC) as an agent for PRRT was prepared and its biodistribution was studied in rats. Methods:The ...

Radiolabeling and evaluation of two 177Lu-labeled bis-phosphonates

Introduction: Bone pain palliation therapy is a mandate in handling end-stage cancer patients. The development of new ligands with higher stability, better pharmacokinetics and lower unwanted tissue uptakes (liver and GI) is still ongoing. Methods: In this work Lu-177 labeled (3-amino-1-hydroxypropane-1,1-di-yl)-bis-(phosphonate) (177Lu-pamidronate; 177Lu-PAM ), ...

Development of 153Sm/177Lu-EDTMP as a possible therapeutic complex

Introduction:Targeted radionuclide therapy (TRT) has been demonstrated to be an effective therapeutic tool in patients with disseminated bone metastasis. TRT is generally performed with a single radionuclide. In this study we investigated the feasibility of combined TRT with a high-energy beta emitter (153Sm) and a low energy beta emitter (177Lu) in wistar...